Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors

[1]  Charles Swanton,et al.  Genetic prognostic and predictive markers in colorectal cancer , 2011, Nature Reviews Cancer.

[2]  J. Meyerhardt,et al.  HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. , 2010, The American journal of pathology.

[3]  Shuji Ogino,et al.  Precision of pyrosequencing assay to measure LINE-1 methylation in colon cancer, normal colonic mucosa, and peripheral blood cells. , 2010, The Journal of molecular diagnostics : JMD.

[4]  D. Hunter,et al.  Germline polymorphisms in the one-carbon metabolism pathway and DNA methylation in colorectal cancer , 2010, Cancer Causes & Control.

[5]  E. Otsuji,et al.  A combination of indol-3-carbinol and genistein synergistically induces apoptosis in human colon cancer HT-29 cells by inhibiting Akt phosphorylation and progression of autophagy , 2009, Molecular Cancer.

[6]  L. Prokunina-Olsson,et al.  No effect of cancer-associated SNP rs6983267 in the 8q24 region on co-expression of MYC and TCF7L2 in normal colon tissue , 2009, Molecular Cancer.

[7]  D. Spiegelman,et al.  A prospective cohort study shows unique epigenetic, genetic, and prognostic features of synchronous colorectal cancers. , 2009, Gastroenterology.

[8]  M. Batzer,et al.  The impact of retrotransposons on human genome evolution , 2009, Nature Reviews Genetics.

[9]  Ö. Türeci,et al.  Selective activation of tumor growth-promoting Ca2+ channel MS4A12 in colon cancer by caudal type homeobox transcription factor CDX2 , 2009, Molecular Cancer.

[10]  J. Meyerhardt,et al.  Prognostic significance and molecular associations of 18q loss of heterozygosity: a cohort study of microsatellite stable colorectal cancers. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  Shuji Ogino,et al.  Aurora-A expression is independently associated with chromosomal instability in colorectal cancer. , 2009, Neoplasia.

[12]  J. Kawai,et al.  The regulated retrotransposon transcriptome of mammalian cells , 2009, Nature Genetics.

[13]  J. Issa,et al.  Global DNA Hypomethylation (LINE-1) in the Normal Colon and Lifestyle Characteristics and Dietary and Genetic Factors , 2009, Cancer Epidemiology Biomarkers & Prevention.

[14]  I. Pogribny,et al.  DNA hypomethylation in the origin and pathogenesis of human diseases , 2009, Cellular and Molecular Life Sciences.

[15]  Peter Kraft,et al.  PIK3CA mutation is associated with poor prognosis among patients with curatively resected colon cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Shuji Ogino,et al.  JC virus T-antigen in colorectal cancer is associated with p53 expression and chromosomal instability, independent of CpG island methylator phenotype. , 2009, Neoplasia.

[17]  R. Lothe,et al.  Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers , 2008, Molecular Cancer.

[18]  M. Loda,et al.  Cohort study of fatty acid synthase expression and patient survival in colon cancer. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[19]  Shuji Ogino,et al.  A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. , 2008, Journal of the National Cancer Institute.

[20]  John Quackenbush,et al.  Comprehensive Biostatistical Analysis of CpG Island Methylator Phenotype in Colorectal Cancer Using a Large Population-Based Sample , 2008, PloS one.

[21]  H. Kazazian,et al.  Retrotransposons Revisited: The Restraint and Rehabilitation of Parasites , 2008, Cell.

[22]  W. Grady,et al.  Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.

[23]  Robert Brown,et al.  CpG island methylator phenotype (CIMP) in cancer: causes and implications. , 2008, Cancer letters.

[24]  Edward L. Lee,et al.  Impact of BRAF, MLH1 on the incidence of microsatellite instability high colorectal cancer in populations based study , 2008, Molecular Cancer.

[25]  S. Ogino,et al.  LINE‐1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer , 2008, International journal of cancer.

[26]  S. Ogino,et al.  PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations. , 2008, Neoplasia.

[27]  J. Herman,et al.  Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. , 2008, Carcinogenesis.

[28]  R. Jaenisch,et al.  Activation and transposition of endogenous retroviral elements in hypomethylation induced tumors in mice , 2008, Oncogene.

[29]  R. Sinha,et al.  Genomic methylation of leukocyte DNA in relation to colorectal adenoma among asymptomatic women. , 2008, Gastroenterology.

[30]  Oliver Fiehn,et al.  Metabolite profiling of human colon carcinoma – deregulation of TCA cycle and amino acid turnover , 2008, Molecular Cancer.

[31]  K. Kawakami,et al.  Methylation levels of LINE‐1 repeats and CpG island loci are inversely related in normal colonic mucosa , 2007, Cancer science.

[32]  J. Meyerhardt,et al.  Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer. , 2007, Neoplasia.

[33]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[34]  J. Issa,et al.  LINE-1 Hypomethylation in Cancer Is Highly Variable and Inversely Correlated with Microsatellite Instability , 2007, PloS one.

[35]  M. Loda,et al.  Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. , 2007, The Journal of molecular diagnostics : JMD.

[36]  K. Bertrand,et al.  Induction of DNA Hypomethylation by Tumor Hypoxia , 2007, Epigenetics.

[37]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[38]  M. Loda,et al.  Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP , 2007, Modern Pathology.

[39]  M. Loda,et al.  CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. , 2006, The Journal of molecular diagnostics : JMD.

[40]  M. Loda,et al.  Down‐regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer , 2006, The Journal of pathology.

[41]  M. Loda,et al.  Correlation of Pathologic Features With CpG Island Methylator Phenotype (CIMP) by Quantitative DNA Methylation Analysis in Colorectal Carcinoma , 2006, The American journal of surgical pathology.

[42]  M. Fraga,et al.  Chromosomal instability correlates with genome-wide DNA demethylation in human primary colorectal cancers. , 2006, Cancer research.

[43]  R. Ward,et al.  Colorectal cancer: a model for epigenetic tumorigenesis , 2006, Gut.

[44]  M. Loda,et al.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies , 2006, Gut.

[45]  P. Laird,et al.  CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.

[46]  M. Loda,et al.  Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer. , 2006, Neoplasia.

[47]  J. Issa,et al.  DNA methylation changes after 5-aza-2'-deoxycytidine therapy in patients with leukemia. , 2006, Cancer research.

[48]  Shuji Ogino,et al.  Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. , 2006, The Journal of molecular diagnostics : JMD.

[49]  Kentaro Yamashita,et al.  Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. , 2006, Cancer cell.

[50]  W. Schulz.  L1 Retrotransposons in Human Cancers , 2006, Journal of biomedicine & biotechnology.

[51]  M. Loda,et al.  Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component , 2006, Modern Pathology.

[52]  S. Kakar,et al.  The Relationship between Global Methylation Level, Loss of Heterozygosity, and Microsatellite Instability in Sporadic Colorectal Cancer , 2005, Clinical Cancer Research.

[53]  Christian B. Woods,et al.  Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.

[54]  R. Jaenisch,et al.  Global loss of imprinting leads to widespread tumorigenesis in adult mice. , 2005, Cancer cell.

[55]  S. Matsui,et al.  Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. , 2005, Cancer research.

[56]  R. Jaenisch,et al.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Shuji Ogino,et al.  Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer , 2005, Clinical Cancer Research.

[58]  T. Bestor.  Transposons Reanimated in Mice , 2005, Cell.

[59]  M. Loda,et al.  Sensitive sequencing method for KRAS mutation detection by Pyrosequencing. , 2005, The Journal of molecular diagnostics : JMD.

[60]  R. Hansen,et al.  Hemimethylation and Non-CpG Methylation Levels in a Promoter Region of Human LINE-1 (L1) Repeated Elements* , 2005, Journal of Biological Chemistry.

[61]  Apiwat Mutirangura,et al.  Distinctive pattern of LINE-1 methylation level in normal tissues and the association with carcinogenesis , 2004, Oncogene.

[62]  A. Evsikov,et al.  Retrotransposons regulate host genes in mouse oocytes and preimplantation embryos. , 2004, Developmental cell.

[63]  Jef D. Boeke,et al.  Transcriptional disruption by the L1 retrotransposon and implications for mammalian transcriptomes , 2004, Nature.

[64]  J. Issa,et al.  A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. , 2004, Nucleic acids research.

[65]  R. Jaenisch,et al.  Induction of Tumors in Mice by Genomic Hypomethylation , 2003, Science.

[66]  M. Speek.  Antisense Promoter of Human L1 Retrotransposon Drives Transcription of Adjacent Cellular Genes , 2001, Molecular and Cellular Biology.

[67]  P. Laird,et al.  MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.

[68]  B. Leggett,et al.  Characterisation of a subtype of colorectal cancer combining features of the suppressor and mild mutator pathways. , 1999, Journal of clinical pathology.

[69]  M. Ehrlich,et al.  DNA demethylation and pericentromeric rearrangements of chromosome 1. , 1997, Mutation research.